Maxim Group initiated coverage of Atossa Genetics (NASDAQ:ATOS) with a “buy” rating and 12-month price target of $2. The stock closed at 33 cents on Jan. 25.Read More
Atossa Genetics (NASDAQ:ATOS) has priced a public offering of 1,150,000 common shares at a price of $2.50 a share for gross proceeds of about $2,875,000.
Atossa Genetics also granted underwriters a 45-day option to purchase up to an additional 172,500 shares to cover over-allotments. The offering is expected to close on Sept. 6.Read More